Podcasts about cgms

Episode 2648: Vinnie Tortorich talks with Robert Soulliere about learning to just breathe for performance, mindfulness, your nervous system, and more.  https://vinnietortorich.com/2025/05/just-breathe-with-robert-soulliere-episode-2648 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE -  Just Breathe Robert helps people learn how to breathe properly for performance and health. (3:00) Breathing correctly can improve your nervous system, mental clarity, and even your eyesight. (8:00) Doing Zone 2 cardio while breathing through your nose can improve your health. (11:30) The longer you can stay in an aerobic state, the less lactic acid builds up. (20:00) The goal is to keep your breathing calm regardless of the intensity of the exercise. (23:00) Breathing can help regulate your emotions and your nervous system response. (35:00) You can get the effects of Viagra or nitrous oxide by breathing through your nose; proper breathing increases NAD, which is a vasodilator. (41:00) Breathing through the mouth is similar to rusting (causing oxidation) because it allows free radicals to remain in your system. (43:00) Robert enjoys using measuring devices such as continuous glucose monitors (CGMs) that track numbers over time. He uses a device that measures HRV by using an EKG patch attached to your chest. Robert has training events to help optimize performance and mindfulness. You can find out more about Robert and his training programs at breatheryourpower.com. More News If you are interested in the NSNG® VIP group, closed for registration, but you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook, is available!  You can go to  You can order it from .  Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day!  Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen.  There's a new NSNG® Foods promo code you can use! The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. https://nsngfoods.com/   PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere:  Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere:  REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere:  FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: 

Welcome to "Thriving in Midlife Redefining Aging with Wellness" the podcast where we discuss how to live an extraordinary life in every aspect. I'm your host, Kellie Lupsha, a high-performance health coach, who is delighted to be your guide to vitality.In this episode, Dr. Heidi and I dive into practical tips to help you feel your best as summer approaches. Whether you're planning trips, prepping for family adventures, or just want to stay on track with your health goals, we've got you covered. Learn how small changes can make a big difference in your energy, cravings, and overall well-being.Key Highlights:Discover two key habits that can transform how you fuel your body.Learn how small adjustments in your daily habits can lead to big results over time.Discover why protein is key to energy, cravings, and long-term health—and how much you really need.Find out an easy formula to calculate how much water your body needs daily.Explore how tools like CGMs and Chat GPT can simplify healthy choices, even while traveling.A Two-Week Challenge: Commit to a simple audit to uncover what's working—and what's not.Key Takeaways"…it's huge where that insulin goes, a lot of negative things go with it. So keep it steady. And it can be a powerhouse of energy for you.”—Dr. Heidi Iratcabal“No matter if we're talking about food or finances or whatever we need to audit where we're at. Then pick one of them and make the change.” —Kellie Lupsha*FREE GIFT

Richard Mackey, Chief Technology Officer at CCS, focuses on the challenges faced by patients with diabetes and multiple morbidities, as well as their healthcare providers, in managing their conditions.  CCS has developed the Living Connected approach to connect patients, providers, and payers, and promotes the role that durable medical equipment companies and pharmacists can play in supporting patients and doctors. Recognizing that patients are more than their disease, CCS addresses social determinants of health to provide education and care coordination. Richard explains, "CCS is a company that is in the business of chronic care management. We focus on delivering products and services to patients with a variety of chronic care conditions. But foremost among these for us is diabetes. We're very focused on being able to provide solutions and services for folks who are managing their diabetic condition."  "On the machine learning side, we have a tremendous amount of data and information about how our patients will understand the devices they might be using. For example, continuous glucose monitors or CGMs are an important standard of care that we work with a lot of patients across the US to equip them, find the right device, help them begin using that device, and best understand what it can do and how it can help them make better decisions to manage their conditions." "We might talk to the patient once or twice a month. We might be talking to them multiple times within a quarter. In some cases, we're interacting with a patient more often than others in the ecosystem, maybe more often than even their physician in terms of the number of interactions per month or period, even their health insurance provider. So all that interaction helps give us information and data to draw insights on what those patients might need, what's most important to them, and how they interact with us. We can also work with a variety of other sources to bring information together. And by using the machine learning tools that we've developed, we can understand things that are important to them. So, it might be around the product or specific information related to the plan or the payer they're working with." #CCSMed #Diabetes #ChronicCare #CGM #Healthcare #DigitalHealth #MedicalAI ccsmed.com Listen to the podcast here

Richard Mackey, Chief Technology Officer at CCS, focuses on the challenges faced by patients with diabetes and multiple morbidities, as well as their healthcare providers, in managing their conditions.  CCS has developed the Living Connected approach to connect patients, providers, and payers, and promotes the role that durable medical equipment companies and pharmacists can play in supporting patients and doctors. Recognizing that patients are more than their disease, CCS addresses social determinants of health to provide education and care coordination. Richard explains, "CCS is a company that is in the business of chronic care management. We focus on delivering products and services to patients with a variety of chronic care conditions. But foremost among these for us is diabetes. We're very focused on being able to provide solutions and services for folks who are managing their diabetic condition."  "On the machine learning side, we have a tremendous amount of data and information about how our patients will understand the devices they might be using. For example, continuous glucose monitors or CGMs are an important standard of care that we work with a lot of patients across the US to equip them, find the right device, help them begin using that device, and best understand what it can do and how it can help them make better decisions to manage their conditions." "We might talk to the patient once or twice a month. We might be talking to them multiple times within a quarter. In some cases, we're interacting with a patient more often than others in the ecosystem, maybe more often than even their physician in terms of the number of interactions per month or period, even their health insurance provider. So all that interaction helps give us information and data to draw insights on what those patients might need, what's most important to them, and how they interact with us. We can also work with a variety of other sources to bring information together. And by using the machine learning tools that we've developed, we can understand things that are important to them. So, it might be around the product or specific information related to the plan or the payer they're working with." #CCSMed #Diabetes #ChronicCare #CGM #Healthcare #DigitalHealth #MedicalAI ccsmed.com Download the transcript here

After putting her Type 2 Diabetes into remission within 3 months and getting off medications after 6 months following the Keto diet, Josephine Barbarino became an activist for Ketogenic Metabolic Therapies. She is the founder and CEO of the Keto Live Project—an organization on a mission to inform and educate about the power of food and the connection between our diet, insulin resistance, our metabolic health, and our immune system. She is also a highly successful architect. In this episode, Dr. Brian and Josephine talk about… (00:00) Intro (01:21) Josephine's career as an architect and how her architectural experience has assisted her in her new venture as a Keto-Activist (08:32) Josephine's health journey and why she pivoted in her career to became a Keto-Activist (24:06) Mood and cognitive improvement on the keto diet (29:05) Why metabolic health is worsening in Europe (33:27) Tailoring your low carb diet to your individual physiology (37:12) Why everyone should AT LEAST be eating real, Whole Foods (40:09) Tips for using CGMs effectively while on the keto diet (43:28) Informed consent and why medical professionals are massively deficient in nutritional knowledge (46:21) The upcoming Keto Live Conference (6/9 - 6/13) (59:30) The speaker line-up at the Keto Live Conference For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Josephine Barbarino: European Keto Live Centre: https://www.european-keto-live-centre.com/ Keto Live Project IG: https://www.instagram.com/keto_live_project/ Keto Live Conference IG: https://www.instagram.com/ketoliveconference/   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

In this empowering episode, we sit down with Ben Azadi to dive into the key concepts behind his new book, Metabolic Freedom. Ben breaks down what it truly means to be metabolically flexible—the ability to efficiently switch between burning fat and glucose for fuel—and how this flexibility is a cornerstone of optimal health. We explore practical tools to assess your metabolic health, including the pros and cons of continuous glucose monitors (CGMs) versus traditional blood tests. Ben also shares actionable steps to enhance your metabolism, from dietary strategies and fasting protocols to detoxifying your environment from hidden toxins that silently disrupt metabolic function. We close the conversation with how your thoughts and beliefs directly impact your biology, and why cultivating a positive, empowered mindset is essential for achieving true metabolic freedom. Whether you're just starting your metabolic health journey or looking to fine-tune your biohacking routine, this episode offers a wealth of insights and inspiration.Ben Azadi, the founder of Keto Kamp, has over 17 years of experience in the health industry, and he's the author of four best-selling books, including his latest Keto Flex. Ben is the author of the upcoming book Metabolic Freedom, published with Hay House. Ben has been the go-to source for intermittent fasting and the ketogenic diet since 2013.He is known as 'The Health Detective' because he investigates dysfunction, and he educates, not medicates, to bring the body back to normal function. Ben is the founder of Keto Kamp; a global brand bringing awareness to ancient healing strategies such as the keto diet and fasting. Ben is the host of a top 15 podcast, The Metabolic Freedom Podcast which won Keto Podcast of The Year (2022) by The Metabolic Health Summit. Ben has the fast growing Ben Azadi YouTube channel with over 400,000 subscribers and 25 million video views, and TikTok channel with over 330,000 subscribers and over 50 million video views.SHOW NOTES:0:39 Welcome to the show!3:06 About Ben Azadi4:08 Welcome him to the podcast! 5:49 How to know if you're metabolically inflexible7:32 Symptoms of Insulin Resistance9:38 What is “Metabolic Freedom”?14:03 Glucose on labs vs CGMs17:05 Initial steps to improving metabolism19:41 Sacrificing sleep to burn fat21:32 Environmental toxins & metabolic dysfunction24:58 Microplastics28:57 Supporting mitochondrial health31:53 *ALIGN MAT*33:31 *PIQUE TEA35:42 Benefits of Melatonin38:24 Are vegetable oils as bad as smoking a cigarette?44:22 Why grains are NOT healthy in the U.S49:27 You don't have a weight problem53:55 Belief systems around our health1:00:10 Vitamin G1:03:15 FREE BOOK1:04:51 Thanks for tuning in!RESOURCES:Website: www.benazadi.com Instagram: www.instagram.com/thebenazadi LinkedIn: https://www.linkedin.com/in/benazadi/ Facebook: www.facebook.com/thebenazadi YouTube: www.youtube.com/ketokamp TikTok: https://www.tiktok.com/@thebenazadi Podcast: The Metabolic Freedom PodcastMyAlignMat - code: BIOHACKERBABES to save $250Pique TeaPuoriEffecty - Save $50 with code BIOHACKERBABESOur Sponsors:* Check out Puori: https://Puori.com/BIOHACKERBABESSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

Join me as I chat with Steph Smith to discusses startup opportunities in the AI era, focusing on both AI-enabled ideas and tech-agnostic concepts that remain valuable despite technological disruption. She presents detailed concepts for personal data dashboards, health data integration platforms, and AI-enhanced dating apps, explaining how these ideas address existing market gaps and could be monetized **$5,000 GREG'S LETTER GIVEAWAY (sponsored by Beehiiv)** - No purchase necessary - Open worldwide 18+ (void FL, NY, Quebec, Italy, Spain, Brazil & where prohibited) - How to enter: 1️⃣ Subscribe at http://gregisenberg.com/ 2️⃣ Reply to the welcome email with “Entering the $5K giveaway” (one per person) 3️⃣ **Like the YouTube video and comment what you'd do with the $5k** - Entry window: 19 May 2025 → 26 May 2025 (ET) - Winner chosen at random and emailed on 28 May 2025; must claim within 48 h - Prize: $5,000 USD via PayPal or wire or what the sponsor chooses - Odds depend on entries. Taxes = winner's responsibility. - Not sponsored by YouTube or any social platform. **Full Official Rules:** https://docs.google.com/document/d/1KSkNYH3lryT9GEXTaFkRYAQaYyla0C-YcXP0IDkNw2Y/edit?usp=sharing Timestamps: 00:00 - Intro 03:01 - Startup Idea 1: Open Pages Creator 11:16 - Startup Idea 2: Lead Magnet Creator 14:26 - Startup Idea 3: Integrated Health Dashboard 21:59 - Startup Idea 4: Directory GPTs 24:54 - Startup Idea 5: AI-Powered Dating App Key Points: • Open Pages: Creating customizable personal data dashboards that display lifestyle metrics (fitness, habits, hobbies) • Health Data Integration: A platform that centralizes health information from various sources (CGMs, wearables, medical records) with AI analysis • Directory GPTs: Converting existing web directories into custom GPTs for personalized recommendations • AI-Powered Dating: Dating apps that match based on compatibility metrics beyond appearance using AI analysis LCA helps Fortune 500s and fast-growing startups build their future - from Warner Music to Fortnite to Dropbox. We turn 'what if' into reality with AI, apps, and next-gen products https://latecheckout.agency/ BoringMarketing — Vibe Marketing for Sale: thevibemarketer.com Startup Empire - a membership for builders who want to build cash-flowing businesses https://www.startupempire.co FIND ME ON SOCIAL X/Twitter: https://twitter.com/gregisenberg Instagram: https://instagram.com/gregisenberg/ LinkedIn: https://www.linkedin.com/in/gisenberg/ FIND STEPH ON SOCIAL X/Twitter: https://x.com/stephsmithio Internet Pipes:https://internetpipes.com/ Surfer Diary: http://surferdiary.com/stats .

Continuous Glucose Monitors (CGMs) have exploded in popularity, promising everything from weight loss to personalised health insights — but are they really delivering? To help us make sense of the science, we're joined by Dr. Javier González, Professor of Nutrition and Metabolism at the University of Bath. Javier recently co-authored a study exploring how CGMs impact non-diabetic adults, and found that they might be giving misleading feedback and even encouraging unhelpful dietary choices. In This Episode, We Cover: Blood sugar 101  What CGMs are and how they work The key findings from Dr. González's recent study Common myths and misconceptions about glucose tracking. Are CGMs actually beneficial for people without diabetes? The risks of relying too heavily on health tech Simple, science-backed strategies for managing blood sugar — without a monitor Live Show Tickets - ⁠⁠⁠⁠⁠https://cadoganhall.com/whats-on/the-wellness-scoop-with-ella-mills-and-rhiannon-lambert/⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

In today's episode, Mercedes Pollmeier shares some research and personal experience from wearing a Continuous Glucose Monitor for a month! Take a closer look together at health, climbing performance, energy regulation, and eating habits. Mercedes talks functionality, benefits, and how a CGM can be used as a self-improvement tool. Hear about her journey, how it helped her understand her body's response to food and exercise, optimize her nutrition, and improve her overall well-being. Join Modus Training with this 3 month membership special! https://www.modusathletica.com/offers/C5hDL5aq If you'd like to work one-on-one with me, visit my website for more details https://www.modusathletica.com/coaching Intro To Training Masterclass is free way to work with me: https://www.modusathletica.com/masterclass 00:01:05 Why I wore a CGM 00:02:01 What are CGMs and how do they work 00:08:58 What happens in your body when your glucose rises 00:12:07 Why use a CGM if you don't have diabetes 00:17:54 How can a CGM help your climbing performance 00:31:13 Common questions about CGMs

Why do so many of us struggle with fat gain, blood sugar spikes, and insulin resistance—even when we think we're eating healthy? In this episode, Dr. Andreas Eenfeldt sits down with Dr. Mario Kratz, PhD, the nutrition scientist behind the popular YouTube channel *Nourished by Science*, to expose the food environment that's setting us up to fail. They dig deep into: - How fat storage breaks down and fuels disease - The myths surrounding CGMs and “normal” blood sugar - Why insulin resistance starts earlier than we think - And what actually works for long-term health and weight loss.

In this cutting-edge episode of the podcast, we explore the powerful intersection of artificial intelligence (AI), wearable technology, and the pharmaceutical industry. Our special guest, Marco Benitez, CEO and co-founder of Rook AI, shares how real-time biometric data from wearables like Apple Watch, Dexcom, and Oura Ring is revolutionizing clinical trials, remote patient monitoring, and digital health solutions.From HRV (heart rate variability) to glucose levels, discover how wearable biosensors, when combined with advanced AI algorithms, enable early detection of adverse events, improved patient engagement, and real-world evidence for drug efficacy. If you're in healthtech, pharma R&D, clinical operations, or digital therapeutics, this episode is a must-listen!

Jill and Chris interview Dr. Paul Kolodzik, who uses the technology of continuous glucose monitoring (CGM) in his metabolic health practice. With the use of CGMs, he helps his patients achieve weight loss and improved health. He has also integrated the prudent use of the new weight loss medications into his practice. His new book: The Continuous Glucose Monitoring Revolution, presents a comprehensive program for metabolic health success using CGMs and limited use of weight loss medications. Dr. Kolodzik graduated from the University of Notre Dame and completed medical school and residency at Wright State University where he served as chief resident. He is a founding member of the Society of Metabolic Health Practitioners. He is board-certified by both the American Board of Preventive Medicine and the American Board of Emergency Physicians. In a thirty-year emergency room career, he has cared for many patients in crises and has witnessed firsthand the failures of mainstream diets and the medical system overall, which prioritizes medications and surgery over diet and lifestyle changes to prevent and reverse disease.  For more information and links mentioned in this episode, please visit our website at BecomingElli.com

This week on We Are T1D, Mike and Jack unpack the reality of living with unreliable diabetes tech — from Freestyle Libre sensor failures to the emotional stress of depending on CGMs that just don't work. After five sensor fails in six weeks, Mike's had enough, and he's not holding back.Also in this episode:⚠️ How sensor failures trigger CGM anxiety (and why warm-ups now feel like betting on luck)

Did you know that simply tracking your steps each day can double your chances of reaching your weight loss goals? In this episode, I explored how digital tech tools like fitness trackers, heart rate monitors, smart scales, continuous glucose monitors (CGMs), streaming fitness apps, and sleep tech can support your weight loss journey. I shared personal experiences using devices like the Fitbit, Apple Watch, and Garmin, emphasizing how they helped me stay accountable and understand my body's needs better. From real-time data on your activity and heart rate to insights on your sleep and glucose levels, these tools offer valuable support—but they're not without downsides, such as cost, data accuracy, and the risk of obsession. Ultimately, I encouraged picking one or two tools based on your biggest challenges and reminded my listeners that while tech can help, real progress still depends on showing up and staying consistent.  Tune in to discover which digital tools can supercharge your weight loss journey and help you stay on track effortlessly!   Episode Highlights: Benefits and drawbacks of fitness trackers  How heart rate monitors help optimize fat burn and endurance training Insights from smart scales on body composition beyond weight Role of continuous glucose monitors (CGMs) in personalized nutrition Advantages and limitations of streaming fitness apps Impact of sleep tech on metabolism and weight loss Integration of digital tools through platforms like Apple Health and MyFitnessPal Tips for choosing the right tech based on your biggest health challenge Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Tired of hearing “just go on the pill” for your PCOS? In this episode of Medical Disruptors, Dr. E sits down with Danielle Hamilton—the woman who reversed her PCOS naturally, without meds or crash diets. Danielle reveals how PCOS isn't a hormone issue—it's a metabolic one. And the key to healing? Fix your insulin resistance. From blood sugar crashes to red light therapy, CGMs to circadian rhythms, this conversation flips everything you've heard about PCOS on its head.

In Part 1 of this two-part series, Etienne Nichols sits down with regulatory strategist Dr. Mike Drues to explore the nuanced differences between prescription (Rx) and over-the-counter (OTC) medical devices. They demystify key terms, regulatory classifications, and the growing trend of label expansions from Rx to OTC—highlighting real-world examples like CPAP machines and continuous glucose monitors (CGMs). This episode unpacks how intended users, environments, and risk tolerances shape device categorization, and why usability testing is far more complex than many realize. Whether you're developing a consumer health product or preparing a label expansion strategy, this is a must-listen for your regulatory roadmap.Key Timestamps[03:05] – What defines an OTC vs. prescription medical device?[06:45] – Market size of OTC devices and major product categories10:00 – Label expansion: moving from Rx to OTC status13:22 – The role of intended use environment in OTC classifications20:40 – Examples of devices in each FDA class that are OTC26:30 – Prescription devices used in home settings vs. true OTC31:15 – Characteristics that qualify devices for OTC status37:55 – Self-diagnosis, self-selection, and patient usability challenges43:00 – “Reasonably foreseeable misuse” and how to interpret guidance49:05 – Do you design for the lowest common denominator?56:10 – Representing diverse user populations in usability testing1:01:45 – Can a device launch OTC first? The case for wellness-to-Rx strategies1:08:15 – FDA's perspective on device safety: OTC vs. RxQuotes“The best regulatory professionals don't just know the rules—they know the exceptions.”Dr. Mike Drues reminds us that exceptional regulatory strategy lies in understanding nuance, especially in OTC classifications where edge cases can redefine categories.“Just because a device is used at home doesn't mean it's over the counter.”This insight challenges a common industry assumption, underscoring the importance of carefully defining intended use and environment early in development.Key TakeawaysOTC ≠ Low Risk by Default – Many Class II and even rare Class III devices can be OTC; it's more about intended user, use environment, and risk mitigation than class alone.Label Expansion Requires Strategy – Transitioning a device from prescription to OTC isn't just about removing a doctor's role—it may involve new usability studies, labeling changes, and potentially a 510(k) or de novo submission.Understand the "Intended Use Environment" – FDA doesn't just care about where the device is used, but how those environmental parameters (like light, humidity, and user training) affect safe operation.Usability Testing Must Reflect Real Users – For OTC devices, human factors validation must account for diverse educational backgrounds, not just ideal users.Don't Rely on Labels Alone – Whether or not users read (or understand) instructions must be tested, not assumed. Intuitive design is critical for OTC success.References & ResourcesEtienne Nichols on LinkedInGreenlight Guru Medical Device Classification Webinar with Mike Drues (for explanation on device classes)FDA Guidance: “Factors to Consider When Making Benefit-Risk Determinations in Medical Device...

In this jam-packed episode, Dr. Jeremy Pettus and Dr. Steve Edelman team up with special guest Dr. David Ahn to break down the latest and greatest in diabetes technology for 2025. From extended-wear CGMs to fully automatic hybrid closed-loop pumps and dual-hormonal systems, this episode is your complete guide to what's available now and what's coming soon. Whether you're on MDI, using a pump, or considering a tech upgrade, this conversation will help you navigate the expanding world of devices—and find the right setup for you.Key Topics:Extended-Wear CGMs: The Dexcom G7 now lasts over 15 days—and the Eversense implantable sensor lasts a full year.Over-the-Counter CGMs: Learn about Dexcom Stelo and Abbott Lingo, designed for people without diabetes.New Pump Launches: Including Tandem Mobi, Beta Bionics iLet, Sequel Twist, and Medtronic's MiniMed™ 780G with Simplera Sync sensor.Medtronic Simplera Sync: What to know about its U.S. launch, wear time, and integration with the 780G system.Dual-Hormone Systems: Explore how glucagon is being used alongside insulin to prevent lows and simplify diabetes management.Ketone Monitoring: Continuous ketone sensors are on the horizon, and they could change how we detect and prevent DKA.Improved App Integration: Discover updates in CGM and pump interfaces for iPhone and Android, including Libre 3+ and universal app platforms.Customizing Your Combo: Why matching the right CGM with the right pump (or sticking with MDI) is more doable—and more important—than ever. ★ Support this podcast ★

Not all calories are equal. Tracking your macronutrient intake, using AI capabilities, can help you improve your body composition, facilitate weight loss, and boost exercise performance. The three macronutrients are protein, fat, and carbohydrates, with fiber a subset of carbs. Josh Clemente & Dr. Dominic D'Agostino discuss the new macros-tracking feature in the Levels app, the purpose and importance of each macronutrient, how to use macros-tracking in conjunction with biomarker data to improve health and fitness, and how easy the app's AI functionality is to use.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠⁠Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. Levels Members gain access to the Levels app and continuous glucose monitors (CGMs), providing real-time feedback on how diet and lifestyle choices impact your metabolic health.Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

Join endocrine experts Lubaina S. Presswala, DO, FACOI, FACE; Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, FADCES; and Viral N. Shah, MD, FACE, as they explore the latest in continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems for managing diabetes. In this episode, they discuss the practical applications of diabetes technology, patient selection, shared decision-making, and considerations for device use in specific populations, including athletes and pregnant individuals. This conversation provides valuable insights to help clinicians navigate device options and enhance outcomes across diverse patient scenarios.

In recent years, the intersection of artificial intelligence (AI) and healthcare has led to groundbreaking innovations that promise to transform the way we monitor and manage chronic conditions. One of the most significant advancements in this realm is the development of AI systems that predict glucose levels without the need for invasive sensors. January AI, a precision health company, is at the forefront of this revolution, leveraging years of research and cutting-edge technology to provide users with accurate glucose predictions based on a variety of personal and dietary factors.The Evolution of Glucose MonitoringTraditionally, individuals with diabetes have relied on continuous glucose monitors (CGMs) or smartwatches to track their blood sugar levels. These devices, while effective, can be costly and invasive, requiring users to wear sensors that may cause discomfort. January AI has recognized the limitations of these methods and has developed a three-tiered approach to glucose prediction. The initial versions of their product relied on data collected from CGMs, establishing a baseline for users while they wore these devices. This foundational data allowed the company to create predictive models that could still function after the sensor was removed, offering users a glimpse into their glucose levels without continuous monitoring.The latest iteration, dubbed version three, represents a significant leap forward. By analyzing a multitude of demographic factors, such as age, gender, height, weight, body mass index (BMI), and even ethnicity, January AI has created a probabilistic model that can predict glucose levels with remarkable accuracy - without any need for physical sensors. This model utilizes a database of 54 million food items and can even analyze food images, providing users with detailed nutritional information and predictive glucose responses based on their dietary choices.A New Era of Convenience and AccessibilityThe implications of this technology are profound. For individuals with diabetes, managing blood sugar levels is a daily challenge that can significantly impact their quality of life. The ability to predict glucose levels without the need for invasive devices opens up new avenues for convenience and accessibility. Users can simply take a picture of their food, and the AI will analyze it to provide a comprehensive breakdown of its nutritional content, including calories, macronutrients, and a predictive glucose curve.Imagine a scenario where a person with diabetes enjoys a bagel topped with cream cheese. Instead of having to rely on a CGM to monitor their blood sugar response, they can take a photo of their meal, and the AI will estimate not only the caloric and nutritional content but also predict how their glucose levels will react. This immediate feedback can empower users to make informed dietary choices, ultimately leading to better management of their condition.The Future of Diabetes ManagementThe innovation showcased by January AI is not just a technological marvel; it represents a paradigm shift in how we think about diabetes management. By integrating AI with dietary analysis and personal health data, the company is paving the way for a more personalized and user-friendly approach to health monitoring. This technology is particularly significant as it eliminates the barriers associated with traditional glucose monitoring methods, making it more accessible to a broader population.Moreover, the recognition of January AI's work, including receiving an innovation award from CES and being featured in the Wall Street Journal, underscores the potential impact of their technology on the healthcare landscape. As we look toward the future, the integration of AI in health management systems could lead to more effective, affordable, and non-invasive solutions for chronic conditions beyond diabetes.Conclusion: A Non-Invasive Way to Manage DiabetesThe development of AI systems that predict glucose levels without the need for sensors marks a significant advancement in diabetes management. Companies like January AI are leading the charge, providing innovative solutions that empower individuals to take control of their health. As technology continues to evolve, the promise of AI in healthcare will likely expand, offering new opportunities for improving patient outcomes and enhancing the quality of life for those living with chronic conditions.Interview by Marlo Anderson of The Tech Ranch.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. The most flexible tools for podcasting. Get a 30 day free trial of storage and statistics.

In recent years, the intersection of artificial intelligence (AI) and healthcare has led to groundbreaking innovations that promise to transform the way we monitor and manage chronic conditions. One of the most significant advancements in this realm is the development of AI systems that predict glucose levels without the need for invasive sensors. January AI, a precision health company, is at the forefront of this revolution, leveraging years of research and cutting-edge technology to provide users with accurate glucose predictions based on a variety of personal and dietary factors.The Evolution of Glucose MonitoringTraditionally, individuals with diabetes have relied on continuous glucose monitors (CGMs) or smartwatches to track their blood sugar levels. These devices, while effective, can be costly and invasive, requiring users to wear sensors that may cause discomfort. January AI has recognized the limitations of these methods and has developed a three-tiered approach to glucose prediction. The initial versions of their product relied on data collected from CGMs, establishing a baseline for users while they wore these devices. This foundational data allowed the company to create predictive models that could still function after the sensor was removed, offering users a glimpse into their glucose levels without continuous monitoring.The latest iteration, dubbed version three, represents a significant leap forward. By analyzing a multitude of demographic factors, such as age, gender, height, weight, body mass index (BMI), and even ethnicity, January AI has created a probabilistic model that can predict glucose levels with remarkable accuracy - without any need for physical sensors. This model utilizes a database of 54 million food items and can even analyze food images, providing users with detailed nutritional information and predictive glucose responses based on their dietary choices.A New Era of Convenience and AccessibilityThe implications of this technology are profound. For individuals with diabetes, managing blood sugar levels is a daily challenge that can significantly impact their quality of life. The ability to predict glucose levels without the need for invasive devices opens up new avenues for convenience and accessibility. Users can simply take a picture of their food, and the AI will analyze it to provide a comprehensive breakdown of its nutritional content, including calories, macronutrients, and a predictive glucose curve.Imagine a scenario where a person with diabetes enjoys a bagel topped with cream cheese. Instead of having to rely on a CGM to monitor their blood sugar response, they can take a photo of their meal, and the AI will estimate not only the caloric and nutritional content but also predict how their glucose levels will react. This immediate feedback can empower users to make informed dietary choices, ultimately leading to better management of their condition.The Future of Diabetes ManagementThe innovation showcased by January AI is not just a technological marvel; it represents a paradigm shift in how we think about diabetes management. By integrating AI with dietary analysis and personal health data, the company is paving the way for a more personalized and user-friendly approach to health monitoring. This technology is particularly significant as it eliminates the barriers associated with traditional glucose monitoring methods, making it more accessible to a broader population.Moreover, the recognition of January AI's work, including receiving an innovation award from CES and being featured in the Wall Street Journal, underscores the potential impact of their technology on the healthcare landscape. As we look toward the future, the integration of AI in health management systems could lead to more effective, affordable, and non-invasive solutions for chronic conditions beyond diabetes.Conclusion: A Non-Invasive Way to Manage DiabetesThe development of AI systems that predict glucose levels without the need for sensors marks a significant advancement in diabetes management. Companies like January AI are leading the charge, providing innovative solutions that empower individuals to take control of their health. As technology continues to evolve, the promise of AI in healthcare will likely expand, offering new opportunities for improving patient outcomes and enhancing the quality of life for those living with chronic conditions.Interview by Marlo Anderson of The Tech Ranch.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. The most flexible tools for podcasting. Get a 30 day free trial of storage and statistics.

Dr. Paul Kolodzik spent 25 years in emergency medicine watching the long-term consequences of preventable disease. Now, he's helping patients reverse metabolic syndrome using continuous glucose monitors (CGMs), low-carb nutrition, and strength training. In this episode, Dr. Kolodzik explains why blood sugar spikes—not cholesterol—may be the most urgent threat to long-term health. You'll also hear why he believes wearables and strategic use of GLP-1 medications can radically change your health trajectory.How long will you live? Take our quiz today to find out! Visit ageist.com/longevityquizThanks to Our SponsorsTroscriptions — Precision, pharmaceutical-grade nootropics for peak performance. Whether you need laser focus, mental clarity, or a boost in cognitive endurance, Troscriptions delivers science-backed results. Use code: AGEIST for 10% off, or click here.LMNT Electrolytes — Our number one electrolytes for optimal hydration. Listeners receive a free 8-serving sample pack with their purchase at DrinkLMNT.com/AGEIST. Our Place – Our top cookware brand for non-toxic, PFA-free pots and pans. Use code “AGEIST” for 10% off at fromourplace.com Chapters(00:15) Introduction to Metabolic Health and CGMs(03:28) Understanding Fatty Liver Disease and Carbohydrate Impact(06:10) The Role of Continuous Glucose Monitors (CGMs)(09:06) Insulin Resistance and Metabolic Syndrome(12:04) The Relationship Between Blood Sugar and Weight Gain(15:18) Dietary Approaches to Managing Blood Sugar(18:08) The Importance of Personalization in Diet(21:11) Inflammation, Brain Health, and Blood Sugar(24:14) Understanding A1C and Blood Sugar Metrics(29:13) Understanding Blood Sugar Levels(35:15) The Role of Exercise in Insulin Resistance(41:08) Integrating GLP-1 Medications with CGMs(47:25) The Importance of Continuous Glucose Monitoring(51:07) Empowerment Through Data and Personal Health ManagementKey MomentsFatty liver disease isn't from eating too much fat — it's, for most people, excessive carb intake.Once I see it, I can't unsee it. And then you know what's going on with your blood sugar physiology.Strength training reverses insulin resistance. Your muscles are soaking up more insulin and more blood glucoseConnect with Dr. Paul KolodzikCGM Doctor — https://cgm-doctor.comMetabolicMDs Practice — https://metabolicmds.comBook:The Continuous Glucose Monitor Revolution for Non-Diabetics — https://www.amazon.com/dp/B0BHL5YZXVSocial Media: LinkedIn — linkedin.com/in/paulkolodzik/Check out the full interview transcriptConnect With AGEISTNewsletterInstagramSay hi to the AGEIST team!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Learning more about the FDA letter sent to Dexcom, news from ATTD including a bihormonal pump from a Dutch company, time in tight range update, more studies about using insulin and GLP-1 medications, eating chili to prevent gestational diabetes (really!) and more..  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week: Dexcom Dive Brief: A warning letter posted Tuesday by the Food and Drug Administration revealed quality control issues with Dexcom's continuous glucose monitors. The FDA raised concerns with a design change to a component used in the resistance layer of Dexcom's sensors. The sensors with the new component were less accurate than those with the original component, according to the warning letter. Dexcom has ceased distribution of G7 sensors with the component, but the company's response did not address affected G6 sensors. J.P. Morgan analyst Robbie Marcus wrote in a research note Tuesday that the letter concerns a chemical compound that the sensor wire is dipped in. Dexcom began producing the compound internally to add redundancy to its supply chain.   Dive Insight: Dexcom Chief Operating Officer Jake Leach said in an interview with MedTech Dive last week that the company does not expect the warning letter to affect future product approvals, including a 15-day version of its G7 CGM, and there's no need yet to recall products. Dexcom has submitted the device to the FDA and anticipates a launch in the second half of the year.   Marcus, after speaking to company leadership and a quality control expert, wrote that many of the issues outlined in the letter could be addressed quickly. He added that the warning letter could explain minor delays in approval to the 15-day sensor, but Dexcom is still within the 90-day window for a 510(k) submission.   “While there's always a risk this could impede future product approvals,” Marcus wrote, “we do not expect this to materially delay the 15 day G7 sensor approval.”   The warning letter followed an FDA inspection last year of Dexcom's facilities in San Diego and Mesa, Arizona. Marcus wrote that after the FDA requested additional information and a separate 510(k), Dexcom stopped in-sourcing the compound and reverted back to the external supplier.   Dexcom's devices were misbranded because the company did not submit a premarket notification to the FDA before making major changes to the sensors, according to the warning letter. The sensors with the changed coating “cause higher risks for users who rely on the sensors to dose insulin or make other diabetes treatment decisions,” the letter said.     The FDA raised other concerns in the warning letter, including procedures to monitor the glucose and acetaminophen concentrations used in testing of the G6 and G7 CGMs. The FDA also cited problems with Dexcom's handling last year of a deficiency in its G6 sensors with dissolved oxygen content values, a key input for measuring blood glucose levels. https://www.medtechdive.com/news/dexcom-warning-letter-cgm-coating-change/743597/ XX Lots of studies and info out of the recent ATTD conference. One highlight that has been sort of under the radar: a Dutch company has been using a Bihormonal fully closed-loop system for the treatment of type 1 diabetes in the real world. This is a company called Inreda (in-RAY-duh). The Inreda AP® is an automatic system (closed loop) and independently regulates the blood glucose level by administering insulin and glucagon. The AP5 is certified in Europe and is being used in multiple studies and projects. The AP®6 is currently under development. https://www.inredadiabetic.nl/en/discover-the-ap/ https://pubmed.ncbi.nlm.nih.gov/38443309/ XX Let's talk about time in tight range. If you follow me and diabetes connections on social, you likely saw a video I made about this – it blew up last week. If not.. time in range has been a metric for a short while now.. in 2019 there was a consensus report advising a goal of 70% of time in the 70-180 mg/dL range for most people with type 1 diabetes (T1D) and type 2 diabetes (T2D), with modifications for certain subgroups. Recently we've been hearing more about 70-140 mg/dL — for longer periods as “time in tight range (TiTR).” At ATTD there was more talk about calling that range TING, or “time in normal glycemia.     There's a great writeup that I'll link up from the great Miriam Tucker on Medscape about a debate that happened at ATTD. On March 22, 2025, two endocrinologists debated this question at the Advanced Technologies & Treatments for Diabetes (ATTD) 2025. Anders L. Carlson, MD, medical director of the International Diabetes Center (IDC), Minneapolis, took the positive side, while Jeremy Pettus, MD, assistant professor of medicine at the University of California San Diego, who lives with T1D himself, argued that it's too soon.   https://www.medscape.com/viewarticle/should-time-tight-range-be-primary-diabetes-goal-2025a100073q?form=fpf   XX Sequel Med Tech announces its twist pump will be firs paired with Abbott's FreeStyle Libre 3 Plus. The twist has FDA approval for ages 6 and up and is set to begin its commercial launch by the end of June. The pump—designed by inventor Dean Kamen's Deka Research & Development—also incorporates the FDA-cleared Tidepool Loop software program, to record CGM blood sugar readings, make predictions based on trends and adjust its background insulin levels accordingly. https://www.fiercebiotech.com/medtech/sequel-med-tech-connects-twiist-insulin-pump-abbotts-cgm-ahead-market-debut XX Dexcom's longer-lasting CGM sensor looks promising, based on study results presented at the conference. The trial showed that the new 15-day G7 system is slightly more accurate than the current G7. The accuracy of CGM can be measured using MARD (mean absolute relative difference), which shows the average amount a CGM sensor varies from your actual glucose levels (a lower number is better).  The 15-day G7 has a MARD value of 8.0%, about the same as the Abbott Freestyle Libre 3. The Dexcom G7 15 Day is awaiting FDA approval and is not yet available in the U.S.   XX Little bit of news from Modular Medical.. they plan to submit their patch pump to the FDA late summer or fall of this year. The MODD1 product, a 90-day patch pump, features new microfluidics technology to allow for the low-cost pumping of insulin. Its new intuitive design makes the product simple to use and easier to prescribe. It has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery. Modular Medical picked up FDA clearance for MODD1 in September. The company also raised $8 million to end 2024. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. By developing its patented insulin delivery technologies, the company hopes to improve access to glycemic control. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. https://www.drugdeliverybusiness.com/modular-medical-announces-12m-private-placement/ XX More from attd – type 2 news? https://www.drugdeliverybusiness.com/biggest-diabetes-tech-news-attd-2025/ XX Another study that says people with type 1 who use a GLP-1 medication get better outcomes. In this study, those who use GLP-1 with insulin are 55% less likely to have a hyperglycemia-related ED visit, 26% less likely to have an amputation-related visit, and 29% less likely to have a diabetic ketoacidosis (DKA)-related ED visit in the following year compared to those on insulin alone. Although they are not approved for T1D, some patients may receive them off-label or for weight control. Pretty big study for an off label drug: compared 7,010 adult patients with T1D who were prescribed GLP-1s and insulin to 304,422 adult patients with T1D who were on insulin alone.  It is important to note that the rates of new diabetic complications in one year for both groups were around 1%, indicating that these are uncommon outcomes regardless of medication use. https://www.epicresearch.org/articles/some-diabetic-complications-less-likely-among-type-1-diabetics-on-glp-1s   XX Early research here but exposure to antibiotics during a key developmental window in infancy may stunt the growth of insulin-producing cells in the pancreas and boost risk of diabetes later in life The study, is published this month in the journal Science, it's a study in mice. These researchers are working off the idea that when while identical twins share DNA that predisposes them to Type 1 diabetes, only one twin usually gets the disease. She explained that human babies are born with a small amount of pancreatic “beta cells,” the only cells in the body that produce insulin.   But some time in a baby's first year, a once-in-a-lifetime surge in beta cell growth occurs.   “If, for whatever reason, we don't undergo this event of expansion and proliferation, that can be a cause of diabetes,” Hill said.   They found that when they gave broad-spectrum antibiotics to mice during a specific window (the human equivalent of about 7 to 12 months of life), the mice developed fewer insulin producing cells, higher blood sugar levels, lower insulin levels and generally worse metabolic function in adulthood.   in other experiments, the scientists gave specific microbes to mice, and found that several they increased their production of beta cells and boosted insulin levels in the blood. When male mice that were genetically predisposed to Type 1 diabetes were colonized with the fungus in infancy, they developed diabetes less than 15% of the time. Males that didn't receive the fungus got diabetes 90% of the time. Even more promising, when researchers gave the fungus to adult mice whose insulin-producing cells had been killed off, those cells regenerated. Hill stresses that she is not “anti-antibiotics.” But she does imagine a day when doctors could give microbe-based drugs or supplements alongside antibiotics to replace the metabolism-supporting bugs they inadvertently kill.   .   “Historically we have interpreted germs as something we want to avoid, but we probably have way more beneficial microbes than pathogens,” she said. “By harnessing their power, we can do a lot to benefit human health.”     https://www.eurekalert.org/news-releases/1078112 XX Future watch for something called BeaGL - created by researchers at the University of California Davis and UC Davis Health who were inspired by their own personal experiences with managing T1D.   BeaGL is designed to work with CGMs and has security-focused machine learning algorithms to make predictive alerts about anticipated glucose changes, which are sent to a device. In this case, a smartwatch. The end goal is for BeaGL to be completely automated to reduce the cognitive load on the patient, particularly for teens. It's still in research phase but six student with T1D have been using it for almost a year.     https://health.ucdavis.edu/news/headlines/with-ai-a-new-metabolic-watchdog-takes-diabetes-care-from-burden-to-balance/2025/02 XX Investigators are searching for a way forward after two long-term diabetes programs were terminated following the cancellation of their National Institutes of Health (NIH) funding, the result of federal allegations that study coordinator Columbia University had inappropriately handled antisemitism on campus. The programs include the three-decades-old Diabetes Prevention Program (DPP) and its offshoot, the Diabetes Prevention Program Outcomes Study (DPPOS). “We are reeling,” said David Nathan, MD, a previous chair of both the DPP and the DPPOS and an original leader of the landmark Diabetes Control and Complications Trial. Nathan is also founder of the Massachusetts General Hospital Diabetes Center in Boston, one of the 30 DPPOS sites in 21 states. On March 7, the Trump administration cancelled $400 million in awards to Columbia University from various federal agencies. While Columbia University agreed on March 21 to changes in policies and procedures to respond to the Trump administration's charges, in the hopes that the funding would be restored, DPPOS Principal Investigator Jose Luchsinger, MD, told Medscape Medical News that as of press time, the study was still cancelled. https://www.medscape.com/viewarticle/diabetes-prevention-program-cancellation-colossal-waste-2025a100076h XX XX Type 2 diabetes may quietly alter the brain in ways that mimic early Alzheimer's. This was only an animal study – but researchers say the high comorbidity of type 2 diabetes (T2D) with psychiatric or neurodegenerative disorders points to a need for understanding what links these diseases.   https://scitechdaily.com/how-diabetes-quietly-rewires-the-brains-reward-and-memory-system/ XX Eating chili once a month when you're pregnant seems to lower the risk of developing gestational diabetes. This is a real study! While chili showed a link to lower gestational diabetes risk, dried beans and bean soup had no significant effect, even among women who ate them more frequently. Some studies suggest that diets high in beans and legumes, including the Mediterranean diet, reduce GDM risk. While studies link beans to lower diabetes risk, their specific impact on GDM remains unclear. This study analyzed data from 1,397 U.S. pregnant women who participated in the Infant Feeding Practices Study II, conducted between 2005 and 2007. Chili consumption varied significantly by race, education, household size, income, supplemental nutrition status, and region. Non-Hispanic Black mothers consumed the most (0.33 cups/week), while those with higher income and education levels consumed less. Regional differences also influenced chili intake. One possible mechanism for chili's effect is capsaicin, a bioactive compound found in chili peppers, which has been linked to metabolic benefits in other studies. However, further research is needed to confirm this potential role in GDM prevention. Dried bean and bean soup consumption had no clear association with GDM. The study highlights limitations due to self-reported dietary data and the need for more detailed dietary measures. https://www.news-medical.net/news/20250317/Could-a-little-spice-in-your-diet-prevent-gestational-diabetes.aspx XX

Send us a textDr. Laura Buchanan and Dr. Matt Calkins are returning guests on our show! Be sure to check out her first appearance on episode 521, and both them on episode 566 of Boundless Body Radio!Dr. Laura Buchanan is a board-certified family medicine physician with a passion for using lifestyle modification as the first-line standard of care wherever possible. Since entering the field of medicine Laura has been interested in the intersections of longevity, metabolic health, lifestyle changes and chronic disease.Dr. Matt Calkins is board certified in family medicine and loves studying the science of longevity, the optimization of all phases of health, and applying his knowledge to physician and patient wellness. Matt earned his M.D. from the University of Florida and holds a B.Sc. in physics. He has published papers on food addiction, CGMs, and diabetes.When they're not active in the clinic, their favorite things to do are going hiking and playing tennis, trying out new low-carb recipes, and celebrating wins both big and small with patients. Their idea of a perfect date is printing out medical studies and debating them with each other over a massive ribeye and broccoli!Find Dr. Laura Buchanan at-https://doctortro.com/IG- @laurabuchananmdTW- @laurabuchananmdSubstack- Aging SuccessfullyFind Dr. Matt Calkins at-TW- @MattCalkinsMDThe TOWARD Health StudyFind Boundless Body at- myboundlessbody.com Book a session with us here!

Wendy Lund isn't just a powerhouse in healthcare marketing — she's also a longtime family friend, thanks to her working alongside my sister Lisa years ago -- also in healthcare marketing -- then becoming neighbors and "besties."  As a result, I also know Wendy is a longtime advocate for women's health, and is as passionate about promoting good information as she is about, well, her dog, Yogi! Yogi And that is one cute dog: spoiler alert in case you miss the video. As Chief Client Officer of Health@WPP, former CEO of GCI Health, and former Chief Communications Officer at Organon, Wendy has been a force in transforming how we talk about — and invest in — women's healthcare. In May 2025 she's being honored with the Pinnacle Award by MM+M for her leadership and impact. The Imperative for Information and Innovation around Women's Health - Health@WPP at SXSW  In yet another heartfelt, informative, and often funny conversation apropos Women's History Month, Wendy explains why Health@WPP believes wise innovation, factual and  frequent information around women's healthcare is an imperative. Those are the pillars driving that progress — and why that's not just good for society, but great for business.

In this episode of the Primal Potential Podcast, we're diving into three powerful but simple strategies to help you optimize your blood sugar, improve your insulin sensitivity, and increase your energy levels. These are real-world, easy-to-implement hacks that go beyond the usual “eat less sugar” advice. Before we get started, grab your copy of my new Fat Loss E-Book! Here's the link. And, head over to my new YouTube channel to subscribe and turn on notifications before the new Carb Series kicks off next week.  Hack #1: Get Sunlight First Thing in the Morning ☀️ Did you know that getting direct sunlight within the first hour of waking helps reset your circadian rhythm, which plays a major role in blood sugar regulation and insulin sensitivity? Pairing this with light movement (like a 10-minute walk or some gentle stretching) can improve how efficiently your body uses glucose before breakfast. What the Science Says: On average, exposure to sunlight improved insulin sensitivity by 18.75%. Median improvement was 18%, meaning half of people experienced even greater benefits. Range of effects: Sunlight exposure improved insulin function by 15-22%. Glucose tolerance: Participants who got more sunlight saw a 12-16% improvement in how well their bodies processed carbohydrates.

What diet should you follow? Metabolic health experts say it doesn't matter whether you're keto, vegan, or otherwise if you focus on three simple principles, which will help reduce your risk for cancer and nonalcoholic fatty liver disease. Dr. Swaranjit Bhasin and Dr. Casey Means discuss the biomarkers to ask your doctor about, why they matter, how to improve those biomarkers with accessible tips, and why liver health is a big key to overall health.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠https://levels.link/wnl⁠⁠⁠

What role do continuous glucose monitors (CGMs) play in optimizing nutrition for everyone—not just diabetics? Join host Crystal O'Keefe as she dives deep into this topic with MetPro registered dietitian coaches, Bianca Wagner and Travis Wilson. Together, they break down how CGMs work, the insights they provide, and why they're gaining popularity among health-conscious individuals.Discover the link between glycemic index, glycemic load, and blood sugar control, and how MetPro's tailored nutrition strategies align with these concepts. Whether your goal is fat loss, muscle building, or simply maintaining steady energy levels, this episode is packed with practical tips to empower your health journey.Tune in for expert advice, relatable examples, and actionable strategies to help you take charge of your nutrition using data-driven tools like CGMs. Don't miss out on this insightful discussion!All episodes of The MetPro Method can be found anywhere you get podcasts or go to MetPro.co/podcast. Be sure to follow, rate, and review. You can learn more about MetPro at MetPro.co!

Send us a textToday we had the pleasure of welcoming Priya Tew* to the pod.  If you are in recovery from an eating disorder, have ever experienced disordered eating or just struggle to know what you should be eating, this episode is for you.Ela and I are confirmed anti-dieters but this chat reinforced for us the need for nuanced conversations. conversations that explore the messy middle.We learned so much from Priya in this short episode and know you will too.*Priya Tew is an award winning registered dietitian and leading expert in eating disorders and irritable bowel syndrome (IBS). With nearly two decades of experience, she is passionate about helping people build a healthier relationship with food. Priya runs her own practice, Dietitian UK, and an eating disorder recovery community called the Recovery Tribe. She is also the author of two books (the DASH diet and the complete low FODMAP Diet plan), sharing her knowledge and expertise to support those struggling with food and gut health. Alongside her clinical work, Priya collaborates with food brands, contributes to the media, and balances life as a mum of six.Visit Priya's website.Follow Priya on InstagramCheck out Priya's Facebook account Please reach out if you would like some support with your relationship to food OR movement. Ela currently has limited spaces for Intuitive Eating coaching and if you'd like to reconnect with movement, contact Christine.AND if you enjoyed this episode, please share and follow the 'Find Your Strong podcast' and if you have time, write us a short review. It would honestly mean the world. Love to you all, Ela & Christine x

Can freezing rice make it healthier? Are cold potatoes better for blood sugar? And do viral blood sugar hacks actually work?In this episode, I sit down with Dr. Mindy Patterson, a registered dietitian and researcher, to break down the science behind resistant starch, glycemic index, and continuous glucose monitoring—and what actually matters for your patients.What You'll Learn:✅ What resistant starch is and how it affects blood sugar✅ Why glycemic index might be outdated (and what to use instead)✅ The truth about CGMs—do they help patients without diabetes?✅ How food prep (like chilling rice or potatoes) changes glucose response✅ Whether the Glucose Goddess' viral blood sugar hacks hold up to scienceIf your patients are asking about blood sugar spikes, resistant starch, or viral food trends, this episode is a must-listen!Connect with Dr Mindy:LinkedInRenutrin SupplementAny Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week. Support the show!If you love the show and want to help me make it even better, buy me a coffee to help me keep going! ☕️Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

In this episode of Healthcare on the Rocks: Employee Benefits with a Twist, hosts Brittany Hardaway and Rachael Baumgartner sit down with Dr. Janet Young, Clinical Analytics Advisor at Springbuk, to unpack a growing challenge for employers: the rising costs of diabetes care. ‍Dr. Young shares that diabetes-related spending has surged by 38% over the past three years—far outpacing other chronic conditions. A major driver? The skyrocketing use of GLP-1 agonists, medications originally developed for diabetes but now widely used for weight loss. "More than 40% of members with type 2 diabetes filled a prescription for GLP-1s last year—double the rate from four years ago," she notes. While these medications offer powerful benefits, including improved glucose control and cardiovascular protection, their costs continue to climb, creating tough decisions for employer-sponsored health plans.As employers strategize for the future, Dr. Young emphasizes three key priorities: tracking diabetes trends, proactively addressing prediabetes, and ensuring equitable access to care.The conversation also explores the expanding role of continuous glucose monitors (CGMs) beyond type 1 diabetes patients. These devices, which eliminate the need for fingersticks, are gaining traction among insulin-dependent type 2 diabetics and could have broader applications—potentially even helping prediabetic individuals prevent disease progression. Dr. Young also highlights the stark disparities in diabetes treatment based on social determinants of health (SDOH), with more vulnerable populations less likely to access newer medications and monitoring tools. Key TakeawaysDiabetes costs are rising fast – Diabetes spending jumped 38% over three years, driven largely by the rising use of GLP-1 agonists.GLP-1 medications are in high demand – More effective than older treatments and linked to weight loss, GLP-1s are now used by over 40% of type 2 diabetics.CGMs are expanding beyond insulin users – Real-time glucose tracking is gaining popularity and could play a role in prediabetes prevention.Social determinants of health matter – Diabetes rates double in high-vulnerability populations, yet these groups have less access to newer treatments.Employers should focus on three things – Monitor diabetes trends, tackle prediabetes early, and reduce treatment disparities.Stay in Touch!Connect with Janet Young on LinkedInGet the complete 2025 Employee Health Trends report and other related resourcesConnect with our co-hosts Brittany Hardaway and Rachael BaumgartnerHave feedback, questions, or suggestions for show ideas? Send them to us at podcast@springbuk.com. Please rate and review us on your favorite podcast platform, and share it with your friends and colleagues. We appreciate you and thank you for listening! Theme music: "Overboard" by Stay Outside

Oatmeal has long been considered a heart-healthy breakfast, but is it really as good for us as we think? In this episode, Jonathan and Sarah break down the great oat debate. First, they explore the different types of oats - instant, rolled, and steel-cut and how processing impacts their nutritional value. Then, they put oats to the test using continuous glucose monitors (CGMs), comparing instant to steel-cut, with and without toppings, to demonstrate how blood sugar works. Sarah also discusses wider debates around oats: Are pesticides a concern? Is oat milk as healthy as it claims? Finally, she shares the ultimate guide to choosing the healthiest oats - and for those who prefer alternatives, she's got delicious, nutrient-packed swaps to try.

In this episode, hosts Dr. Erin Faules and Dr. Jeff Graham dive deep into advanced testing methods that detect health risks before they become life-threatening. They highlight cardiovascular disease prevention, cancer screening, and metabolic health monitoring, emphasizing how new tools like Cleerly heart scans, full-body MRIs, and CGMs can transform modern healthcare. The conversation also covers VO2 Max, Dexa scans, and epigenetic testing, offering listeners a data-driven approach to optimizing health and longevity.

In this episode, we're diving deep into a topic that's crucial but often overlooked - hypoglycemia unawareness. This happens when you don't feel the symptoms of low blood sugar, which can be dangerous and even life-threatening. I'm sharing stories, real-life examples, and practical tips on how to manage this silent risk, especially with tools like CGMs and some creative solutions like having low snacks everywhere or training a diabetic alert dog. Whether you're newly diagnosed or have been living with diabetes for years, this episode is a must-listen. Let's talk about how we can stay safe even when our body isn't giving us those warning signs!   Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching   RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff Join our EXCLUSIVE Facebook group! https://www.facebook.com/groups/266766620895432 Watch my food breakdowns here → https://www.youtube.com/@yourdiabetesinsider   LET'S TALK! Instagram: @manoftzeel Tiktok: @manoftzeel  

In this episode, we welcome back Nick Norwitz for Part 2 of our deep dive into metabolism, food addiction, and dietary nuances. We cover everything from broken metabolisms to the role of hormones in weight regulation, the impact of glycemic load, and the ongoing debate about fruit, dairy, olive oil, and the carnivore diet. If you've ever wondered about food science versus food fear-mongering, this is the episode for you! Key Topics Discussed: 1. Understanding “Broken Metabolism” The difference between metabolic dysfunction and metabolic perception. The role of insulin and other hormones in fat storage and hunger regulation. Why glycemic load matters more than calorie counting in weight loss. The importance of patience in metabolic healing, especially after years of processed food consumption. 2. Why Weight Loss Can Plateau Metabolic adaptation and how fat cells retain memory. How food labels can be misleading and the importance of tracking glycemic response. The role of continuous glucose monitors (CGMs) in fine-tuning nutrition choices. 3. Fruit and the Fear of Fructose Debunking the myth that all fructose is bad. How the small intestine processes fructose before it reaches the liver. The importance of context: different fruits have different effects on blood sugar. Recommendations for lower-glycemic fruits, such as berries, for those with insulin resistance. 4. Olive Oil and Muscle Health The role of oleuropein in mitochondrial function and aging muscles. How olive leaf extract might help improve muscle metabolism. The importance of choosing high-quality olive oil for maximum benefit. 5. Dairy and Cardiovascular Health New research showing that cheese may actually reduce cardiovascular disease risk. Why saturated fat in dairy is not necessarily harmful. The importance of individual tolerance—some people thrive on dairy, while others find it triggering. 6. The Carnivore Diet: Is It Right for You? Carnivore as an elimination diet rather than a meat-only ideology. How some people experience relief from autoimmune and gut health issues by eliminating plant foods. Why sustainability and long-term adherence matter more than short-term results. Key Takeaways: Metabolic health is adaptable: Your body can heal, but patience and consistency are key. Fruit isn't the enemy: Choose fruits wisely based on your metabolic health and glycemic response. Whole foods matter: The effects of food go beyond macros—consider nutrient density and processing. Individualization is key: Whether it's carnivore, keto, or Mediterranean, the best diet is the one that works for you. Resources Mentioned: Nick Norwitz's YouTube Channel: https://www.youtube.com/@nicknorwitzPhD Website: https://www.nicknorwitz.com Scientific Papers Discussed: Adipose Tissue Retains an Epigenetic Memory of Obesity After Weight Loss (Nature, 2024) The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids (Cell Metabolism) Mitochondrial Calcium Uptake and Skeletal Muscle Performance (Cell Metabolism) If you enjoyed this episode, please rate and review us on your favorite podcast platform. Thanks for listening! The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.

Stable glucose levels are a foundation of feeling and looking your best at any age. When glucose levels are more erratic—with spikes and crashes—cravings, weight gain, low energy, health issues, and more can ensue. Jessie Inchauspé and Dr. Casey Means, thought leaders on the topic of blood sugar, discuss simple hacks for keeping glucose levels more stable without resorting to restrictive diets, and they share why stable levels inform health.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. Levels Members gain access to the Levels app and continuous glucose monitors (CGMs), providing real-time feedback on how diet and lifestyle choices impact your metabolic health.Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

What was life with type 1 diabetes like before home glucose meters, fast-acting insulin, or CGMs? In this episode, Dr. Mark talks to Bob, who has been living with T1D for over five decades. Diagnosed in 1972, Bob takes us through his journey of navigating college, sports, and a career with little guidance on diabetes management. He opens up about how he used to keep his diabetes a secret at work, how a major complication changed everything, and how he went from staying quiet to becoming an advocate—including introducing President Biden at the White House. Click HERE to get your FREE copy of Diabetes Sucks and You Can Handle It (just cover shipping)

2025 is set to bring major advancements in diabetes technology, from AI-driven CGMs to new insulin pumps like Medtronic's upcoming 8-series and patch pump, and the Tidepool Loop-based twiist pump. I spoke with Gary Scheiner, a CDCES and author of Think Like a Pancreas, to break down what these innovations mean for diabetes management.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US only)   Read our Blog + Join the Newsletter    Support Diabetech on Patreon  | Diabetech Community Discord   Follow me here: Instagram | Tik Tok | YouTube | Facebook   Gary's Practice Gary's Book Think Like a Pancreas   Watch the Podcast on Youtube   DISCLAIMERS: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.   *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Want to get in touch? Send Claire a message!In Episode 109 of the Eat for Endurance podcast, Hayden James, RDN CSSD CDCES of Satiate Nutrition joins me for a deep dive into blood sugar levels and athletic performance.Hayden is a sports dietitian, Certified Diabetes Care & Education Specialist, and the conference director for the inaugural 2025 Fuel Fest, an endurance and mountain sports nutrition conference for healthcare professionals. She's also an avid trail runner, climber, skier, and lifter based in Salt Lake City, Utah.Hayden and I discuss everything you should know about blood sugar levels as an athlete, including:Which foods and other factors cause blood sugar levels to increaseThe role of insulin in the bodyAcute vs chronic glucose elevationsWhy maintaining "normal" blood sugar levels is important to overall healthWhy a blood sugar spike in itself isn't a bad thingHow to tell if you truly have low blood sugar, or if you're just hungryWhy simple sugars found in sports nutrition products are helpfulDifferent forms of simple sugars that you can use during exerciseThe importance of adequate carb intake for bone health and iron statusWhat might be causing your afternoon slump (hint: it's not the carbs)The use of continuous glucose monitors (CGMs) in non-diabetic athletesWhy athletes should use caution with CGMs, and perhaps even avoid themWe also aim to clear up some of the confusion on this topic to encourage athletes to stop fearing and/or limiting carbs in their diet.Links & Announcements:Follow Hayden on InstagramWatch this episode on YouTubeJoin my new monthly membership service, Fuel for Life Crew, for just $30/monthCheck out my free nutrition downloadsFill out a new client inquiry form if you're interested in 1:1 nutrition coachingSupport the podcast with my Skratch Labs affiliate code EATFORENDURANCE20 Join my Patreon community Get in touch at claire@eatforendurance.comDisclaimer – all information provided is for educational and entertainment purposes only and is in no way meant to replace individual medical and nutrition recommendationsSupport the showThanks for listening! Follow me on Instagram and Facebook (@eatforendurance).

Jessie Inchauspé, also known as The Glucose Goddess, burst onto the Instagram scene in 2018, where she began educating people on how to manage their blood sugar and control glucose ‘spikes'. An overnight sensation, she now sells books, supplements, courses and recipes all focused on how to manage blood sugar levels. But how do we actually define a glucose ‘spike'? And are her glucose ‘hacks' really revolutionary? Join us, two Registered Dietitans, as we dive into the world of CGMs, blood sugar regulation and Jessie Inchauspé's Glucose Revolution.  Want to support the show and get bonus episodes? Join our Patreon! https://www.patreon.com/nutritionformortals Don't want to miss any episodes in the future? Make sure to subscribe wherever you listen to podcasts! Things we talked about and additional reading:  Glucotypes study reveal new patterns of glucose dysregulation Continuous glucose profiles in healthy subjects under everyday life conditions and after different meals Glucose Revolution Book  More on glucose spikes from Mario Kratz, PhD For feedback or to suggest a show topic email us at nutritionformortals@gmail.com Feel free to contact our real, live nutrition counseling practice **This podcast is for information purposes only, is not a substitute for individual medical or mental health advice, and does not constitute a patient-provider relationship**

In this dynamic episode of the Fusionary Health Podcast, Dr. Shivani Gupta welcomes Dylan Gemelli, a biohacking trailblazer and fitness guru, to explore the future of health optimization. From hormone balancing and advanced peptides to transforming your metabolism, Dylan breaks down the strategies that have made him a trusted expert to movie stars, fitness celebrities, and millions of followers worldwide. He shares his journey from weight struggles to becoming a biohacking advocate, combining fitness fundamentals with tools like CGMs, red light therapy, and peptides to boost longevity and performance. Key Highlights: •        The Fitness-Biohacking Fusion: Dylan's approach to blending traditional fitness methods with modern biohacking tools for powerful results. •        The Peptide Revolution: How peptides like BPC 157 and tesamorelin are reshaping healing, fat loss, and muscle growth. •        Transforming Metabolism: Why healthy fats, personalized nutrition, and eating timing are game-changers for energy and wellness. •        Hormone Optimization for All: The untapped potential of testosterone and estrogen balance for both men and women. •        Navigating the Wellness Market: How to identify high-quality supplements and tools in an oversaturated industry. •        The Power of Self-Discovery: Dylan's reflections on why true health starts with understanding your body and habits. Why You Should Tune In: Discover advanced strategies to elevate your fitness, energy, and longevity. From peptides to metabolism hacks, Dylan shares insights to help you align your habits with your health goals and take charge of your wellness journey.

Diet and exercise culture tends to prioritize calorie restriction and calorie burning via cardio workouts. While fat loss is beneficial, building and maintaining healthy muscle mass is also crucial for metabolic health and longevity. Dr. Gabrielle Lyon and Dr. Casey Means discuss Lyon's book “Forever Strong,” why strength-training should be a priority for workout routines, how muscle is the body's metabolic currency, and why boosting protein intake aids in adding and preserving muscle mass. Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠ Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. Levels Members gain access to the Levels app and continuous glucose monitors (CGMs), providing real-time feedback on how diet and lifestyle choices impact your metabolic health. Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

If your organization is looking to meet community needs for the benefit of the public, whether it be infrastructure or programming, you can ask your federal elected officials to legislate that project so Congress will send money to fund it. If this sounds familiar, it is. Years ago, it was called earmarks or federal appropriations, but around 2011 this funding source went away (or did it?). Join our very informative conversation with Tonia Brown-Kinzel, GPC, CGMS, for a history lesson on this funding source, plus a step-by-step process for participating in the new process, which is known as Congressionally Directed Spending.   JOIN THE FUNDRAISING HAYDAY COMMUNITY: Become a member of the Patreon   SHOW NOTES: Senators – Congressionally Directed Spending (CDS) General Guidance on Fiscal Year 2025 Appropriations Requests – US Senator Committee on Appropriations   Representatives – Community Projects Funding (CPF) FY25 Member Request Guidance   Tonia's FY2026 Federal Appropriations Links & Resources   WHERE TO FIND OUR GUEST: Tonia Brown-Kinzel LinkedIn The Grant Plant

Spikes, crashes, excursions, and elevated numbers. Blood sugar in real time, overnight, and over time is on a lot of active midlife women's minds. But what do we really know about what this all means…and what it doesn't, especially when it comes to long term health? This week's guest Oxford nutrition scientist and globally recognized type 2 diabetes expert Dr. Nicola Guess helps sort through all things elevated glucose and helps separate what we need to worry about with what we don't. Nicola Guess, RD, MPH, PhD, is a dietitian based in London specializing in the prevention and management of type 2 diabetes. She is currently an associate professor at the University of Westminster, Research Fellow at King's College London, and Head of Nutrition Research at the Dasman Diabetes Institute in Kuwait. She also runs her own private clinical practice. Her primary research interests are in the prevention and management of type 2 diabetes, including the effects of nutrients on the underlying pathophysiology of type 2 diabetes. Dr Guess is a National Institute of Clinical Excellent (NICE) scholar investigating meal provision for inpatients with diabetes; a member of the NICE expert committee; a member of the Diabetes UK Clinical Study Group, and previously a Winston Churchill Travel Scholar investigating approaches to type 2 diabetes prevention in the UK and China and a Diabetes UK Academic Health Partnership Fellow investigating the role of diet in the prevention of type 2 diabetes. You can learn more about her work and follow her research at drguess.substack.com/ResourcesErratic glucose in normoglycaemic athletes: insufficient protein? blogHow useful are CGMs for athletes? blogBlood Glucose Levels of Subelite Athletes During 6 Days of Free Living, Journal of Diabetes Science and Technology (JDST)Join the Feisty Girona Gravel Camp: https://www.thomsonbiketours.com/trips/feisty-girona-gravel-camp/ Subscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page Follow Us on Instagram:Feisty Menopause: @feistymenopause Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Support our Partners:Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/ Nutrisense: Go to nutrisense.io/hitplay and book a call with a Registered Dietitian Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ This podcast uses the following third-party services for analysis: Spotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/Podcorn - https://podcorn.com/privacyPodscribe - https://podscribe.com/privacy

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sana announces beta cell transplantation without the need for immunosuppresion drugs, Modular Medical teams up with Nudge BG for a brand new completely closed-loop system, the FDA moves forward to crack down on compounded Ozempic and Mounjaro, Dexcom and Abbott bury the legal hatchett for a while, and more.  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:     Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Big news from Sana Biotechnology. Their first in human study of islet cells without any immunosuppression appears to be a success. This is very early and hasn't yet been peer reviewed and published.. but after four weeks, there were no safety issues and the transplanted beta cells were producing insulin. Sana's CEO says  “As far as we are aware, this is the first study showing survival of an allogeneic transplant with no immunosuppression or immune-protective device in a fully immune competent individual. Safe cell transplantation without immunosuppression has the potential to transform the treatment of type 1 diabetes and a number of other diseases.”   I've reached out to Sana to get more on this.. love to talk to them soon.   https://www.bakersfield.com/ap/news/sana-biotechnology-announces-positive-clinical-results-from-type-1-diabetes-study-of-islet-cell/article_d0390fd6-99cb-53bd-b04d-9337121e01bf.html XX FDA says no for sotagliflozin as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD).  Studies showed a meaningful reduction in A1C but a meaningful increase in DKA. The FDA first rejected this in 2019 and was resubmitted last summer. But The advisory committee voted 11 to 3 against the approval of sotagliflozin stating that the benefits of sotagliflozin do not outweight the risks in adults with T1D and CKD. Sotagliflozin is currently approved under the brand name Inpefa to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with 1) heart failure; or 2) type 2 diabetes mellitus, CKD, and other cardiovascular risk factors.  According to Lexicon, Inpefa will continue to be manufactured and made available to patients. https://www.renalandurologynews.com/news/fda-denies-approval-of-zynquista-for-type-1-diabetes-and-ckd/ XX Two companies we've been following are teaming up.. Modular Medical has an FDA clear patch pump and Nudge BG has an adaptive full closed loop. They've announced a new partnership agreement. From the release: Modular Medical's easy-to-use and cost-effective MODD1 insulin pump technology. Our combined system is intended to nudge blood glucose by making small changes to insulin delivery based on estimated glucose inputs from a continuous glucose monitor." Familiar name to some of you, Lane Desborough is the founder of Nudge BG. He says this will be a fully automated system, no mealtime bolusing needed.   https://www.accesswire.com/957703/modular-medical-announces-licensing-and-partnership-agreement-with-nudge-bg XX Beta Bionics filed for an initial public offering on Monday. The company did not disclose the number of shares it will offer or the price range. Beta Bionics plans for shares to be listed on the Nasdaq under the ticker symbol “BBNX.” The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was cleared by the Food and Drug Administration in 2023. Beta Bionics plans to use the proceeds to grow its sales and manufacturing infrastructure and develop new features for its device.   https://www.medtechdive.com/news/beta-bionics-insulin-pump-files-ipo/736805/     XX Tandem Diabetes Care, Inc. signed a multi-year collaboration agreement with the University of Virginia Center for Diabetes Technology (UVA) to advance research and development efforts on fully automated closed-loop insulin delivery systems.   There's a long history here – UVA is where the Control IQ algorithm was developed.  This agreement seems to keep the team together for another decade. https://www.businesswire.com/news/home/20250107162995/en/Tandem-Diabetes-Care-Enters-Multi-Year-Research-Collaboration-with-UVA-Center-for-Diabetes-Technology-for-Development-of-Advanced-Insulin-Delivery-Systems XX New study says insulin is still the best treatment for gestational diabetes, compared to oral glucose-lowering medications. Metformin and gluburide are being closely looked at since they're easier to administer, less costly, and have better acceptance among patients. But this study says insulin was a bit better – slight more babies were born larger for the metformin group, and more moms had hypoglycemia. https://www.medpagetoday.com/obgyn/pregnancy/113651 XX In its Citizen Petition to the FDA, Novo Nordisk argued that there is no clinical need to allow compounding for liraglutide, the type 2 diabetes injection it sells as Victoza. Novo Nordisk last month filed a Citizen Petition with the FDA asking the federal agency to exclude its type 2 diabetes injection Victoza (liraglutide) from a proposed list of drugs eligible for compounding. https://www.biospace.com/fda/novo-launches-citizen-petition-to-block-compounded-victoza XX Bit of an update on compounded terzepatide and semaglutide. The FDA is allowing a grace period of 60 days before starting to enforce the end of allowing compounds of Mounjaro. Meanwhile, semaglutide remains on the FDA's shortage list for several dose strengths, though all doses have been reported as “available” since late October 2024. Compounding pharmacies, especially larger 503B “outsourcing facilities,” maintain they provide an essential public service by offering lower-cost versions of medications that can cost over $1,000 per month. Many insurers still refuse to cover brand-name GLP-1 products for weight loss. Yet  the FDA has reported hundreds of adverse event reports allegedly linked to compounded versions of these drugs, which do not undergo the same rigorous manufacturing inspections and clinical testing as approved brands.   https://www.drugdiscoverytrends.com/compounders-and-drugmakers-clash-over-compounded-weight-loss-drugs-with-fda-in-the-middle/ XX Interesting story here.. this study says a fecal transplant can help people with type 1 and severe gastroenteropathy. The researchers say diabetic gastroenteropathy commonly affects individuals with type 1 diabetes, causing debilitating symptoms like nausea, vomiting, bloating, and diarrhea; however, treatment options remain limited. Researchers conducted a novel clinical trial to test the benefits of FMT in adult patients with type 1 diabetes and severe symptoms of gastroenteropathy, who were randomly assigned to receive either FMT or placebo capsules as the first intervention. After four weeks, Compared with placebo, FMT led to significant changes in the diversity of the gut microbiome. https://www.medscape.com/viewarticle/fmt-shows-early-success-type-1-diabetes-bowel-issues-2025a10000bg XX A couple of weeks ago, listeners told me that the Dexcom geofencing issue we reported on seems to be resolved. Dexcom is now confirming this. Previously, if you had an issue with Dexcom G7 outside of your home country, you couldn't reinstall or use the app without customer support. As of last month, the geofencing issue has now been resolved with the latest Dexcom G7 2.6 app update. Can I travel with my Dexcom G7? | Dexcom XX Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding patent disputes and not sue each other over patents for 10 years.   Dexcom and Abbott previously reached a settlement in 2014 related to their diabetes devices, which included a cross-licensing deal and an agreement not to sue each other until 2021. After that agreement expired, the companies filed a volley of patent lawsuits. https://www.medtechdive.com/news/abbott-dexcom-settle-cgm-patent-lawsuits/736300/  

Join us as Paul and Watto reflect on the past year, discussing some favorite insights gained covering a range of topics, including dental pain management, cardiac amyloidosis, the impact of continuous glucose monitoring on diabetes care, the complexities of diagnosing primary hyperparathyroidism, hepatitis B screening and vaccination, GLP-1 agonists, travel medicine, endometriosis, rhinitis, and recurrent UTIs.  Plus, we feature listener voicemails sharing their favorite episodes and why they love the Curbsiders! No CME for this episode, but claim CME for past shows at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Introduction and Year-End Reflections 02:59 Picks of the Year 05:53 Dental Pain and Oral Care Insights 10:25 Cardiac Amyloidosis 14:33 Listener mail- diabetes 16:33 Neck Pain 19:08 Continuous Glucose Monitoring in Diabetes 23:57 Hyperparathyroidism 30:48  Hepatitis B  34:01 Listener mail- obesity 36:14 Travel Medicine: Malaria, Diarrhea, and Vaccination 40:38 Endometriosis 46:08 Rhinitis and Environmental Allergies 49.24  Recurrent UTIs 55:08 Reflections on Nine Years of Curbsiders Credits Written, Produced, and hosted by: Matthew Watto MD, FACP; Paul Williams MD, FACP Cover Art: Matthew Watto MD, FACP Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Molly Heublein MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Sponsor: AquaTru Today listeners receive 20% OFF any AquaTru purifier! Just go to AquaTru.com and enter code “CURB“ at checkout.   Sponsor: Freed Visit Freed.ai. Use code CURB50 to get $50 off your first month. Sponsor: Quince Go to Quince.com/curb for 365-day returns, plus free shipping on your order! 

We're taking a short winter break, but we'll be back with new shows in time for Christmas and New Years! Can't wait for more new episodes? Sign up for our Patreon with 15% off an annual membership at patreon.com/curbsiders (https://www.patreon.com/c/curbsiders) and get instant access to 40 plus bonus episodes! Step up your diabetes game! Learn the ins and outs of continuous glucose monitors (CGM) including key features, what and how to order, interpreting CGM data (time in range, time above range, etc.), and how to make adjustments to a patient's insulin regimen, aka “insulin pattern matching”. We discuss common scenarios including overnight hypoglycemia, exercise-induced hypoglycemia, post-prandial hyperglycemia, what to do when the patient runs high all the time, and how to incorporate GLP1 agonists and SGLT2 inhibitors into a patient's regimen. Returning guest and Paul's favorite frenemy, Dr. Jeff Colburn (VCU Health) returns! Visit our website for detailed show notes for this episode. Claim free CME for this episode at curbsiders.vcuhealth.org! Sponsor: Freed You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month. Sponsor: OpenEvidence If you haven't tried it out yet check it out, it will save you time and help you make better decisions go to openevidence.com/curbsiders Sponsor: Panacea Legal Physicians deserve to be informed of the risks and benefits of their employment contract. Let Panacea Legal help you today at Panacea.Legal

In today's episode, you'll get to explore the complexities of ketogenic vs. carnivore diets with health coach and independent researcher Jay Feldman. Jay explains why he prefers ketogenic diets over high-protein carnivore diets, focusing on how they rely on fats for energy rather than stressing the body with excess protein. The conversation dives into the hormonal and digestive impacts of high-protein diets, while also acknowledging the short-term benefits they may offer. You'll also discover how to manage stress through food choices, improve carbohydrate utilization, and optimize gut health. Additionally, Jay shares his thoughts on using devices like continuous glucose monitors (CGMs) to measure stress hormones and offers practical advice on incorporating more carbs—like fruits and well-processed grains—into your diet for better energy and balance. His bioenergetic approach to health highlights the importance of cellular energy production and mitochondrial function. We'll also tackle personalized exercise protocols based on individual stress levels, explore the benefits and limits of heat and cold exposure, and discuss the role of caffeine in daily routines. Jay Feldman is a health coach, independent health researcher, and the host of The Energy Balance Podcast. He holds degrees in neuroscience and exercise physiology but chose to forgo medical school after realizing that the conventional medical approach wasn't the solution to the health problems many of us face. After working through various conventional and alternative health paradigms and trialing countless diets, Jay came across the idea that cellular energy is the foundation of health. Embracing this discovery, he now uses the Energy Balance approach to help men and women around the world maximize their cellular energy, optimize their health, and achieve freedom from low-energy symptoms and chronic health issues. Tune in as we dive into the science behind diet, stress management, and exercise to unlock the secrets of achieving your best health! Full show notes: https://bengreenfieldlife.com/feldman2 Episode Sponsors:  Young Goose: Visit younggoose.com and use code BEN10 at checkout to enjoy a 10% discount on your first order.  Organifi Shilajit Gummies: Harness the ancient power of pure Himalayan Shilajit anytime you want with these convenient and tasty gummies. Get them now for 20% off at organifi.com/Ben. BioStack: Get 19% off your three-month supply of NAD Regen at biostack.com/ben. Fatty15: Get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/BEN and using code BEN at checkout. BiOptimizers Black Friday Offer: The biggest discount you can get and amazing gifts with purchase are available only on my page bioptimizers.com/bglife with code BEN10.See omnystudio.com/listener for privacy information.